Cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) have been used as tumor markers for diagnosing ovarian cancer and predicting prognosis (Steffensen et al., 2011; Furrer et al., 2019). This evidence concerns the gene MUC16 and neoplasm.